双轴旋转动态放疗(BROAD-RT)治疗鼻咽癌的整合测试:疗效评估与剂量学分析
本研究在OXRAY环状放疗系统上评估双轴旋转动态放疗(BROAD-RT)对15例鼻咽癌患者的剂量学优势,并与共面VMAT(COVMAT)比较;BROAD-RT显著改善靶区均匀性和适形性,降低脑干、左视神经、臂丛、下颌下腺、口腔及腮腺的剂量指标,所有计划通过整合测试,平均γ通过率(3%/2mm)>95%,中位照射时间209秒。
要点
- BROAD-RT较COVMAT显著改善鼻咽癌靶区均匀性和适形性。
- BROAD-RT降低脑干、左视神经、臂丛、下颌下腺、口腔及腮腺的剂量指标。
- 所有BROAD-RT计划通过整合测试,平均γ通过率(3%/2mm)>95%,中位照射时间209秒。
核心结论
- BROAD-RT在OXRAY系统上通过整合测试,并较COVMAT展示出改善鼻咽癌患者剂量分布的潜在获益。
研究设计与样本
- 研究纳入15例鼻咽癌患者,在RayStation中为每例患者分别创建BROAD-RT和共面VMAT(COVMAT)计划,采用Wilcoxon符号秩检验比较两组计划,P值小于0.05视为有统计学意义;同时评估BROAD-RT从治疗计划系统到OXRAY的剂量投照精度,以γ3%2mm条件下通过率≥95%为通过标准,并评估照射时间。
主要发现
- BROAD-RT较COVMAT显著改善计划靶区的均匀性和适形性。
- BROAD-RT较COVMAT降低脑干D0.03 cc、左视神经D0.03 cc、臂丛D0.03 cc、各下颌下腺Dmean、口腔Dmean及各腮腺Dmean的剂量体积指标。
- 所有BROAD-RT计划通过整合测试,平均γ通过率(3%/2mm)高于95%,中位照射时间为209秒。
关键数值与推荐
- 整合测试通过标准为γ3%2mm条件下通过率≥95%。
- BROAD-RT平均γ通过率(3%/2mm)高于95%,中位照射时间209秒。
- 统计显著性阈值为P值小于0.05。
临床怎么用
- 对于鼻咽癌患者,BROAD-RT可在无需移动治疗床的条件下实现非共面VMAT,并较COVMAT改善靶区均匀性和适形性、降低部分危及器官剂量指标。
- BROAD-RT从治疗计划系统到OXRAY的投照精度通过整合测试,平均γ通过率(3%/2mm)高于95%,中位照射时间209秒。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: OXRAY is a new O-ring-shaped radiotherapy system delivering biaxially rotational dynamic-radiation therapy (BROAD-RT), a technique that enables non-coplanar volumetric-modulated arc therapy (VMAT) for large target volumes without requiring couch movement. The purpose of this study was to evaluate the benefits of BROAD-RT and to perform an integration test to confirm the plan deliverability and its accuracy from the treatment planning system to OXRAY for patients with nasopharyngeal carcinoma. METHODS AND MATERIALS: We compared treatment plans for BROAD-RT and coplanar VMAT (COVMAT) created in RayStation for 15 patients with nasopharyngeal cancer using the Wilcoxon signed-rank test. P values less than 0.05 were considered statistically significant. Additionally, we confirmed the plan delivery accuracy of BROAD-RT from the treatment planning system to OXRAY; gamma passing rates (GPRs) and delivery time were evaluated. The criteria for pass and fail were ≥95 % at γ3%2 mm. RESULTS: BROAD-RT significantly improved the homogeneity and conformity index of planning target volume and reduced dose volume indices compared with COVMAT in D0.03 cc for the brainstem, D0.03 cc for the left optic nerve, D0.03 cc for the brachial plexus, Dmean for each submandibular gland, Dmean for the oral cavity, and Dmean for each parotid gland. All plans for BROAD-RT passed the integration test; the mean GPR (3 %/2 mm) was above 95 % and the median delivery time was 209 s. CONCLUSIONS: BROAD-RT delivered by OXRAY passed the integration test, and it demonstrated the potential benefit of improving the dose distribution compared with COVMAT for patients with nasopharyngeal carcinoma.
引用
- Hiraoka S, Hirashima H, Nakamura M, et al. Integration test of biaxially rotational dynamic-radiation therapy for nasopharyngeal carcinoma: Efficacy evaluation and dosimetric analysis. Radiother Oncol. 2025. PMID: 40189151. doi:10.1016/j.radonc.2025.110879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。